P13726 (TF_HUMAN) Homo sapiens (Human)
Tissue factor UniProtKBInterProSTRINGInteractive Modelling
295 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
52 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal Structure of a ternary complex of Factor VIIa/Tissue Factor/Pyrazinone Inhibitor |
Heteromer P08709; | 100.0 | 2×CA; 1×MG; 1×PY3; | |||
| Crystal structure of the super-active FVIIa variant VYT in complex with tissue factor |
Heteromer P08709; | 100 | 1×BGC; 9×CA; 1×FUC; 10×TMA; 1×0Z7; | |||
| Crystal Structure of a FVIIa-Trypsin Chimera (FT) in Complex with Soluble Tissue Factor |
Heteromer P08709; | 100 | 1×BGC; 9×CA; 1×FUC; 22×TMA; 1×0Z7; 1×POL; | |||
| Crystal Structure of tissue factor-factor VIIa complex |
Heteromer P08709; | 100 | 1×GLC; 1×FUL; 1×0Z6; 1×NAG; 1×CA; | |||
| HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587 |
Heteromer | 100.0 | 1×GOL; | |||
| A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9) |
Heteromer P01837; X5J519; | 100.0 | ||||
| Crystal structure of tissue factor in complex with humanized Fab D3h44 |
Heteromer | 100.0 | ||||
| Crystal Structure of a FVIIa-Trypsin Chimera (YT) in Complex with Soluble Tissue Factor |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 1×0Z6; 1×CA; 1×CIT; | |||
| Crystal Structure of a FVIIa-Trypsin Chimera (ST) in Complex with Soluble Tissue Factor |
Heteromer P08709; | 100.0 | 8×CA; 1×BGC; 1×FUC; 1×0Z6; 2×CAC; | |||
| Crystal structure of a ternary complex of factor VIIa/tissue factor and 2-[[6-[3-(aminoiminomethyl)… |
Heteromer P08709; | 100.0 | 8×CA; 1×CAC; 1×03R; | |||
| Factor VII binding Fab of the bispecific antibody HMB-001 in complex with Factor VII |
Heteromer P08709; | 100.0 | 2×CA; 1×BGC; | |||
| CRYSTAL STRUCTURE OF FVIIA IN COMPLEX WITH A BENZAMIDINE-BASED INHIBITOR |
Heteromer P08709; | 100.0 | 2×CA; 1×MG; 1×GLC; 1×FUC; 2×CL; 1×WSV; | |||
| CRYSTAL STRUCTURE OF FVIIA IN COMPLEX WITH A BENZAMIDINE-BASED INHIBITOR |
Heteromer P08709; | 100.0 | 4×CA; 1×MG; 1×GLC; 1×FUC; 1×WIZ; 2×CL; | |||
| crystal structure of factor VII.stf complexed with pd0297121 |
Heteromer P08709; | 100 | 5×CA; 1×GIL; 1×GLC; 1×FUC; 1×NAG; | |||
| Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 3×MG; 6×CA; 1×BEN; 1×NA; 2×CL; | |||
| Rubidium Sites in Blood Coagulation Factor VIIa |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 3×MG; 4×CA; 6×RB; 1×BEN; 4×CL; | |||
| Complex of Active-site Inhibited Human Coagulation Factor VIIa with Human Soluble Tissue Factor in … |
Heteromer P08709; | 100.0 | 1×GLC; 1×FUC; 3×MG; 6×CA; 1×NA; 2×ZN; 3×CL; 1×PBZ; | |||
| Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 2×MG; 7×CA; 1×0GE; 3×CL; 1×NA; | |||
| Crystal Structure of Benzamidine-Factor VIIa/Soluble Tissue Factor complex. |
Heteromer P08709; | 100.0 | 1×GLC; 1×FUC; 3×MG; 6×CA; 1×NA; 2×ZN; 3×CL; 1×BEN; | |||
| Crystal structure analysis of human Factor VIIa , Souluble tissue factor complexed with BCX-3607 |
Heteromer P08709; | 100 | 1×ASO; 1×FUC; 9×CA; 1×24X; | |||
| Complex of active site inhibited human blood coagulation factor VIIA with human recombinant soluble… |
Heteromer P08709; | 100 | 1×BGC; 1×FUC; 9×CA; 1×0Z6; 1×CAC; 1×CL; | |||
| Crystal structure of DFPR-VIIa/sTF |
Heteromer P08709; | 100.0 | 1×GLC; 1×FUC; 3×MG; 6×CA; 1×0G7; 1×NA; 2×ZN; 3×CL; | |||
| HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT |
Heteromer P00974; P08709; | 100.0 | 1×GLC; 1×FUC; 2×CA; | |||
| Crystal structure of a humanized Fab fragment of anti-tissue-factor antibody in complex with tissue… |
Heteromer | 100 | ||||
| Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-biphenylalanine-Gln-p-aminobenzam… |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 9×CA; 1×3BP; | |||
| Human factor viia-tissue factor complexed with highly selective peptide inhibitor |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 9×CA; 1×567; | |||
| Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-Trp-Gln-p-aminobenzamidine |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 9×CA; 1×P5B; | |||
| Human Factor Viia-Tissue Factor Complexed with propylsulfonamide-D-Thr-Met-p-aminobenzamidine |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 9×CA; 1×PSM; | |||
| Human Factor VIIA-Tissue Factor Complexed with ethylsulfonamide-D-5-(3-carboxybenzyloxy)-Trp-Gln-p-… |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 9×CA; 1×359; | |||
| tf7a_3771 complex |
Heteromer P08709; | 100.0 | 1×771; 9×CA; 1×CAC; 1×FUC; 1×BGC; | |||
| Human Factor Viia-Tissue Factor in Complex with peptide-mimetic inhibitor that has two charged grou… |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 9×CA; 1×3CB; | |||
| Human factor viia-tissue factor complexed with benzylsulfonamide-D-ile-gln-P-aminobenzamidine |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 9×CA; 1×PI0; | |||
| Human Factor Viia-Tissue Factor Complexed with ethylsulfonamide-D-5-propoxy-Trp-Gln-p-aminobenzamid… |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 9×CA; 1×5PI; | |||
| Crystal Structure of Glu-Gly-Arg-Chloromethyl Ketone-Factor VIIa/Soluble Tissue Factor Complex |
Heteromer P08709; | 100.0 | 1×GLC; 1×FUC; 6×CA; 2×MG; 1×0GJ; 1×NA; 2×ZN; 3×CL; | |||
| tf7a_4380 complex |
Heteromer P08709; | 100.0 | 1×380; 9×CA; 1×CAC; 1×FUC; 1×BGC; | |||
| Crystal structure of the complex between human tissue factor extracellular domain and antibody 10H1… |
Heteromer | 100.0 | ||||
| Crystal structure of active site inhibited coagulation factor VIIA in complex with soluble tissue f… |
Heteromer P08709; | 100.0 | 1×BGC; 1×FUC; 1×CA; | |||
| Crystal structure of active site inhibited coagulation factor VIIA mutant in complex with soluble t… |
Heteromer P08709; | 100.0 | 1×GLC; 1×FUC; 1×CA; 1×0Z6; | |||
| Mg2+ Is Required for Optimal Folding of the Gamma-Carboxyglutamic Acid (Gla) Domains of Vitamin K-D… |
Heteromer P08709; | 100.0 | 1×FUC; 2×CA; 1×BGC; 1×0GE; 1×CL; | |||
| Discovery of a Novel Hydroxy Pyrazole Based Factor IXa Inhibitor |
Heteromer P08709; | 100.0 | 1×6NH; | |||
| Dissecting and Designing Inhibitor Selectivity Determinants at the S1 site Using an Artificial Ala1… |
Heteromer P08709; | 100.0 | 1×CR9; | |||
| Factor VIIa Inhibitors: Chemical Optimization, Preclinical Pharmacokinetics, Pharmacodynamics, and … |
Heteromer P08709; | 100.0 | 1×C1B; | |||
| Novel 5-Azaindole Factor VIIa Inhibitors |
Heteromer P08709; | 100.0 | 1×7NH; | |||
| Discovery of Novel Heterocyclic Factor VIIa Inhibitors |
Heteromer P08709; | 100.0 | 1×N1H; | |||
| Human Class I Major Histocompatibility Complex, A02 allele, presenting LLGWVFAQV |
Heteromer A0A140T913; P61769; | 100 | ||||
| THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR AT 1.7 ANGSTROMS RESOLUTION | homo-2-mer | 100.0 | 2×SO4; | |||
| EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR | homo-2-mer | 100 | ||||
| EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR | monomer | 100.0 | ||||
| Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and B… | monomer | 100 | ||||
| Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and B… | monomer | 100 | ||||
| Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and B… | monomer | 100 | ||||
| Phosphorylation of the Cytoplasmic Tail of Tissue Factor and its Role in Modulating Structure and B… | monomer | 100 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4ylq.1.C | monomer | 0.84 | 6×TMA; | 100.00 | ||
| 7wmv.1.B | monomer | 0.61 | 13.64 | |||
1 SWISS-MODEL model built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 8qod.1.C | monomer | 0.78 | 99.00 | |||